Effects of surgical resection and adjuvant therapy on pediatric intracranial ependymomas

References

• Collins V. Wilms' tumor: its behavior and prognosis. J. Louisiana State Med. Soc. (107), 474–480 (1955).
   Google Scholar
• Figarella-Branger D, Civatte M, Bouvier-Labit C et al. Prognostic factors in intracranial ependymomas in children. J. Neurosurg. 93(4), 605–613 (2000).
   Google Scholar
• van Veelen-Vincent ML, Pierre-Kahn A, Kalifa C et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J. Neurosurg. 97(4), 827–835 (2002).
   PubMed Web of Science ®Google Scholar
• Merchant TE. Current management of childhood ependymoma. Oncology (Huntingt).16(5), 629–642, 644; discussion 645–646, 648 (2002).
   Google Scholar
• Allen JC, Siffert J, Hukin J. Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr. Neurosurg. 28(1), 49–55 (1998).
   Google Scholar
• Smyth MD, Horn BN, Russo C, Berger MS. Intracranial ependymomas of childhood: current management strategies. Pediatr. Neurosurg. 33(3), 138–150 (2000).
   PubMed Web of Science ®Google Scholar
• Slavc I, MacCollin MM, Dunn M et al. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int. J. Cancer 64(4), 243–247 (1995).
   PubMedGoogle Scholar
• Rubio MP, Correa KM, Ramesh V et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res.54(1), 45–47 (1994).
   PubMed Web of Science ®Google Scholar
• Sawyer JR, Sammartino G, Husain M, Boop FA, Chadduck WM. Chromosome aberrations in four ependymomas. Cancer Genet. Cytogenet. 74(2), 132–138 (1994).
   Google Scholar
• Vagner-Capodano AM, Gentet JC, Gambarelli D et al. Cytogenetic studies in 45 pediatric brain tumors. Pediatr. Hematol. Oncol. 9(3), 223–235 (1992).
   PubMed Web of Science ®Google Scholar
• Weremowicz S, Kupsky WJ, Morton CC, Fletcher JA. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet. Cytogenet. 61(2), 193–196 (1992).
   PubMed Web of Science ®Google Scholar
• Sieb JP, Pulst SM, Buch A. Familial CNS tumors. J. Neurol. 239(6), 343–344 (1992).
   PubMedGoogle Scholar
• Pierre-Kahn A, Hirsch JF, Roux FX, Renier D, Sainte-Rose C. Intracranial ependymomas in childhood. Survival and functional results of 47 cases. Childs Brain 10(3), 145–156 (1983).
   PubMedGoogle Scholar
• Schiffer D, Chio A, Giordana MT et al. Histologic prognostic factors in ependymoma. Childs Nerv. Syst. 7(4), 177–182 (1991).
   PubMed Web of Science ®Google Scholar
• Asai A, Hoshino T, Edwards MS, Davis RL. Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Childs Nerv. Syst. 8(5), 273–278 (1992).
   PubMedGoogle Scholar
• Grabb PA, Albright AL, Sclabassi RJ, Pollack IF. Continuous intraoperative electromyographic monitoring of cranial nerves during resection of fourth ventricular tumors in children. J. Neurosurg.86(1), 1–4 (1997).
   Google Scholar
• Gilles FH, Tavare CJ, Leviton A et al. Prognostic limitations of the Daumas-Duport grading scheme in infratentorial neuroglial tumors in children. Pediatr. Dev. Pathol. 7(2), 138–147 (2004).
   Google Scholar
• Schwartz DM, Schwartz JA, Pratt RE Jr, Wierzbowski LR, Sestokas AK. Influence of nitrous oxide on posterior tibial nerve cortical somatosensory evoked potentials. J. Spinal Disord. 10(1), 80–86 (1997).
   Google Scholar
• Rorke LB, Gilles FH, Davis RL, Becker LE. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56(Suppl. 7), 1869–1886 (1985).
   PubMed Web of Science ®Google Scholar
• Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ. Disseminated ependymomas of the central nervous system. J. Neurosurg. 85(4), 618–624 (1996).
   PubMed Web of Science ®Google Scholar
• Kim YH, Fayos JV. Intracranial ependymomas. Radiology 124(3), 805–808 (1977).
   PubMed Web of Science ®Google Scholar
• Shaw EG, Evans RG, Scheithauer BW, Ilstrup DM, Earle JD. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int. J. Radiat. Oncol. Biol. Phys. 13(10), 1457–1462 (1987).
   PubMed Web of Science ®Google Scholar
• Salazar OM, Rubin P, Bassano D, Marcial VA. Improved survival of patients with intracranial ependymomas by irradiation: dose selection and field extension. Cancer 35(6), 1563–1573 (1975).
   Google Scholar
• Vanuytsel LJ, Bessell EM, Ashley SE, Bloom HJ, Brada M. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.23(2), 313–319 (1992).
   PubMed Web of Science ®Google Scholar
• Zamecnik J, Snuderl M, Eckschlager T et al. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod. Pathol. 16(10), 980–991 (2003).
   Google Scholar
• Dyer S, Prebble E, Davison V et al. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am. J. Pathol. 161(6), 2133–2141 (2002).
   PubMed Web of Science ®Google Scholar
• Goldwein JW, Glauser TA, Packer RJ et al. Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66(3), 557–563 (1990).
   PubMed Web of Science ®Google Scholar
• Comi AM, Backstrom JW, Burger PC, Duffner PK. Clinical and neuroradiologic findings in infants with intracranial ependymomas. Pediatric Oncology Group. Pediatr. Neurol. 18(1), 23–29 (1998).
   PubMed Web of Science ®Google Scholar
• Wang Z, Sutton LN, Cnaan A et al. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am. J. Neuroradiol.16(9), 1821–1833 (1995).
   Google Scholar
• Pollack IF, Gerszten PC, Martinez AJ et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37(4), 655–666; discussion 666–667 (1995).
   PubMed Web of Science ®Google Scholar
• Healey EA, Barnes PD, Kupsky WJ et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery28(5), 666–671; discussion 671–672 (1991).
   PubMed Web of Science ®Google Scholar
• Jaing TH, Wang HS, Tsay PK et al. Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas. J. Neurooncol.68(3), 255–261 (2004).
   PubMed Web of Science ®Google Scholar
• Perilongo G, Massimino M, Sotti G et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med. Pediatr. Oncol. 29(2), 79–85 (1997).
   PubMedGoogle Scholar
• Lyons MK, Kelly PJ. Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28(5), 659–664; discussion 664–665 (1991).
   PubMed Web of Science ®Google Scholar
• Foreman NK, Love S, Thorne R. Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr. Neurosurg.24(3), 119–125 (1996).
   PubMed Web of Science ®Google Scholar
• Akyuz C, Emir S, Akalan N, Soylemezoglu F, Kutluk T, Buyukpamukcu M. Intracranial ependymomas in childhood – a retrospective review of sixty-two children. Acta Oncol.39(1), 97–100 (2000).
   PubMed Web of Science ®Google Scholar
• Hukin J, Epstein F, Lefton D, Allen J. Treatment of intracranial ependymoma by surgery alone. Pediatr. Neurosurg. 29(1), 40–45 (1998).
   PubMed Web of Science ®Google Scholar
• Awaad YM, Allen JC, Miller DC, Schneider SJ, Wisoff J, Epstein FJ. Deferring adjuvant therapy for totally resected intracranial ependymoma. Pediatr. Neurol. 14(3), 216–219 (1996).
   PubMed Web of Science ®Google Scholar
• Rousseau P, Habrand JL, Sarrazin D et al. Treatment of intracranial ependymomas of children: review of a 15-year experience. Int. J. Radiat. Oncol. Biol. Phys. 28(2), 381–386 (1994).
   PubMed Web of Science ®Google Scholar
• Mork SJ, Loken AC. Ependymoma: a follow-up study of 101 cases. Cancer 40(2), 907–915 (1977).
   Google Scholar
• Palma L, Celli P, Cantore G. Supratentorial ependymomas of the first two decades of life. Long-term follow-up of 20 cases (including two subependymomas). Neurosurgery 32(2), 169–175 (1993).
   Google Scholar
• Merchant TE, Mulhern RK, Krasin MJ et al. Preliminary results from a Phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J. Clin. Oncol. 22(15), 3156–3162 (2004).
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Fuks Z, Hunt M et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys.53(5), 1111–1116 (2002).
   PubMed Web of Science ®Google Scholar
• Chao KS, Majhail N, Huang CJ et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother. Oncol. 61(3), 275–280 (2001).
   PubMed Web of Science ®Google Scholar
• Kovalic JJ, Flaris N, Grigsby PW, Pirkowski M, Simpson JR, Roth KA. Intracranial ependymoma long term outcome, patterns of failure. J. Neurooncol.15(2), 125–131 (1993).
   Google Scholar
• Horn B, Heideman R, Geyer R et al. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J. Pediatr. Hematol. Oncol. 21(3), 203–211 (1999).
   PubMed Web of Science ®Google Scholar
• Massimino M, Gandola L, Giangaspero F et al. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int. J. Radiat. Oncol. Biol. Phys. 58(5), 1336–1345 (2004).
   PubMed Web of Science ®Google Scholar
• Siffert J, Allen JC. Chemotherapy in recurrent ependymoma. Pediatr. Neurosurg. 28(6), 314–319 (1998).
   Google Scholar
• Grill J, Le Deley MC, Gambarelli D et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J. Clin. Oncol.19(5), 1288–1296 (2001).
   PubMed Web of Science ®Google Scholar
• Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med. Pediatr. Oncol. 27(1), 8–14 (1996).
   PubMedGoogle Scholar
• Sutton LN, Goldwein J, Perilongo G et al. Prognostic factors in childhood ependymomas. Pediatr. Neurosurg. 16(2), 57–65 (1990).
   PubMed Web of Science ®Google Scholar
• Oya N, Shibamoto Y, Nagata Y, Negoro Y, Hiraoka M. Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure. J. Neurooncol.56(1), 87–94 (2002).
   PubMed Web of Science ®Google Scholar
• Gornet MK, Buckner JC, Marks RS, Scheithauer BW, Erickson BJ. Chemotherapy for advanced CNS ependymoma. J. Neurooncol. 45(1), 61–67 (1999).
   Google Scholar
• Robertson PL, Zeltzer PM, Boyett JM et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J. Neurosurg. 88(4), 695–703 (1998).
   PubMed Web of Science ®Google Scholar
• Palma L, Celli P, Mariottini A, Zalaffi A, Schettini G. The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Childs Nerv. Syst. 16(3), 170–175 (2000).
   PubMed Web of Science ®Google Scholar
• Needle MN, Goldwein JW, Grass J et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 80(2), 341–347 (1997).
   PubMed Web of Science ®Google Scholar
• Bouffet E, Foreman N. Chemotherapy for intracranial ependymomas. Childs Nerv. Syst.15(10), 563–570 (1999).
   PubMed Web of Science ®Google Scholar
• Grill J, Pascal C, Chantal K. Childhood ependymoma: a systematic review of treatment options and strategies. Paediatr. Drugs 5(8), 533–543 (2003).
   Google Scholar
• Duffner PK, Krischer JP, Sanford RA et al. Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr. Neurosurg. 28(4), 215–222 (1998).
   PubMed Web of Science ®Google Scholar
• Souweidane MM, Bouffet E, Finlay J. The role of chemotherapy in newly diagnosed ependymoma of childhood. Pediatr. Neurosurg.28(5), 273–278 (1998).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Pollack IF, Martinez AJ, Lo KH, Janosky J, Albright AL. Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. Pathol. Res. Pract.192(6), 515–522 (1996).
   Google Scholar
• Helseth E, Due-Tonnessen B, Lote K et al. Ependymoma in children and young adults (0–19 years), report of 25 consecutive cases. Childs Nerv. Syst. 17(1–2), 24–30 (2001).
   PubMed Web of Science ®Google Scholar
• Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB. Infratentorial ependymomas in childhood: prognostic factors and treatment. J. Neurosurg.72(3), 408–417 (1990).
   PubMed Web of Science ®Google Scholar